NPI: 1417227398 · PORTSMOUTH, OH 45662 · Family Medicine Physician · NPI assigned 01/09/2012
Authorized official WHITLATCH, KRISTIE controls 18+ related entities in our dataset. Read more
| Authorized Official | WHITLATCH, KRISTIE (CEO) |
| NPI Enumeration Date | 01/09/2012 |
Other providers sharing the same authorized official: WHITLATCH, KRISTIE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 33,640 | $818K |
| 2019 | 34,304 | $516K |
| 2020 | 33,956 | $1.33M |
| 2021 | 60,665 | $3.24M |
| 2022 | 73,439 | $4.35M |
| 2023 | 109,699 | $4.91M |
| 2024 | 105,696 | $4.51M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 29,374 | 27,263 | $3.61M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 21,416 | 19,506 | $3.26M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21,942 | 20,109 | $2.92M |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 7,660 | 6,960 | $1.39M |
| 80053 | Comprehensive metabolic panel | 31,065 | 26,559 | $730K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,414 | 1,257 | $660K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1,001 | 835 | $475K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 2,049 | 1,776 | $445K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 38,739 | 34,088 | $376K |
| 70450 | Computed tomography, head or brain; without contrast material | 675 | 601 | $280K |
| 84443 | Thyroid stimulating hormone (TSH) | 13,553 | 12,608 | $273K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 526 | 465 | $249K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 1,017 | 857 | $244K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2,149 | 2,028 | $237K |
| 84439 | 8,013 | 7,480 | $202K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 32,832 | 15,893 | $201K |
| 71046 | Radiologic examination, chest; 2 views | 6,355 | 5,559 | $198K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 566 | 537 | $195K |
| 82607 | 5,630 | 5,217 | $177K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 5,073 | 4,725 | $172K |
| 80061 | Lipid panel | 10,837 | 10,111 | $169K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 16,983 | 15,555 | $165K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 7,548 | 6,732 | $158K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1,431 | 1,280 | $157K |
| 83036 | Hemoglobin; glycosylated (A1C) | 7,113 | 6,609 | $136K |
| 87430 | 13,110 | 12,112 | $114K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 223 | 160 | $112K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 301 | 256 | $104K |
| 81001 | 16,471 | 14,885 | $104K | |
| 87081 | 12,286 | 11,264 | $101K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 9,968 | 8,632 | $93K |
| 36415 | Collection of venous blood by venipuncture | 22,666 | 16,968 | $87K |
| 80047 | 4,514 | 3,128 | $85K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 3,559 | 3,019 | $82K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 336 | 261 | $78K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 502 | 405 | $77K |
| 82728 | 3,528 | 3,188 | $76K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 368 | 338 | $59K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 356 | 321 | $59K |
| 71250 | 329 | 303 | $56K | |
| 83550 | 4,209 | 3,820 | $54K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 3,826 | 3,402 | $53K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 420 | 402 | $46K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,252 | 1,054 | $43K |
| 52000 | 61 | 52 | $40K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 94 | 89 | $36K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 150 | 137 | $35K |
| 93017 | 240 | 225 | $32K | |
| 74018 | 787 | 691 | $32K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 44 | 40 | $30K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 101 | 80 | $29K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2,520 | 2,093 | $29K |
| 72100 | 749 | 653 | $29K | |
| 99215 | Prolong outpt/office vis | 158 | 150 | $28K |
| 0223U | 91 | 83 | $27K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1,425 | 1,264 | $27K |
| 84703 | 3,083 | 2,638 | $26K | |
| 80076 | 2,185 | 1,712 | $25K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 601 | 529 | $24K |
| 76536 | 152 | 145 | $23K | |
| 83735 | 2,456 | 2,214 | $23K | |
| 71271 | 107 | 104 | $23K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 574 | 520 | $22K |
| 73130 | 682 | 588 | $22K | |
| 73560 | 812 | 685 | $21K | |
| 73610 | 757 | 671 | $21K | |
| 73630 | 784 | 695 | $21K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 104 | 101 | $20K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 227 | 222 | $18K |
| 73030 | 572 | 496 | $16K | |
| 86140 | 2,045 | 1,852 | $16K | |
| 84153 | 692 | 652 | $16K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 592 | 521 | $14K |
| 71101 | 165 | 135 | $14K | |
| G0378 | Hospital observation service, per hour | 203 | 84 | $13K |
| 86803 | 442 | 408 | $13K | |
| 87807 | 1,794 | 1,629 | $13K | |
| 82378 | 618 | 547 | $13K | |
| 80050 | General health panel | 205 | 197 | $12K |
| 72040 | 240 | 209 | $12K | |
| 82043 | 1,158 | 1,085 | $12K | |
| 85610 | 999 | 850 | $11K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 72 | 68 | $11K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 50 | 50 | $11K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,289 | 1,073 | $11K |
| 73110 | 416 | 360 | $11K | |
| 94729 | 87 | 83 | $10K | |
| 84403 | 313 | 276 | $9K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 1,192 | 1,010 | $9K |
| 88185 | 100 | 91 | $9K | |
| 88184 | 132 | 103 | $9K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 592 | 521 | $8K |
| 94726 | 69 | 69 | $8K | |
| 74450 | 96 | 85 | $8K | |
| 85652 | 1,270 | 1,130 | $7K | |
| 83690 | 2,646 | 2,327 | $7K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1,537 | 1,350 | $7K |
| 84484 | 2,433 | 1,725 | $7K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 834 | 551 | $6K |
| 80074 | 249 | 206 | $6K | |
| 87186 | 859 | 747 | $6K | |
| 73502 | 193 | 174 | $6K | |
| 94060 | 24 | 24 | $5K | |
| 83880 | 803 | 699 | $5K | |
| 73221 | 12 | 12 | $5K | |
| 84145 | 1,604 | 1,442 | $5K | |
| 85730 | 829 | 705 | $4K | |
| 82746 | 467 | 421 | $4K | |
| 74019 | 185 | 158 | $4K | |
| 73080 | 117 | 107 | $4K | |
| 84270 | 148 | 122 | $4K | |
| 82150 | 282 | 232 | $3K | |
| 80069 | 107 | 98 | $3K | |
| 83970 | 99 | 93 | $3K | |
| 71045 | Radiologic examination, chest; single view | 381 | 346 | $3K |
| 86038 | 74 | 66 | $3K | |
| 93975 | 12 | 12 | $3K | |
| 87070 | 231 | 206 | $3K | |
| 84702 | 109 | 87 | $3K | |
| 93922 | 15 | 14 | $3K | |
| 85379 | 876 | 776 | $2K | |
| 86703 | 84 | 75 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 319 | 282 | $2K |
| 72070 | 68 | 62 | $2K | |
| 82947 | 745 | 533 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 29 | 28 | $2K |
| 72125 | Computed tomography, cervical spine; without contrast material | 28 | 25 | $2K |
| 84550 | 210 | 192 | $2K | |
| 82550 | 453 | 375 | $2K | |
| 82784 | 118 | 82 | $2K | |
| 43249 | 22 | 12 | $2K | |
| 87077 | 297 | 241 | $2K | |
| 84100 | 232 | 181 | $2K | |
| 82077 | 68 | 51 | $2K | |
| 70486 | 12 | 12 | $1K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 16 | 14 | $1K |
| 82565 | 126 | 112 | $1K | |
| 83605 | 852 | 732 | $1K | |
| 82570 | 85 | 82 | $1K | |
| 83525 | 30 | 30 | $1K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 2,689 | 2,261 | $1K |
| 86225 | 43 | 43 | $1K | |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 105 | 84 | $1K |
| 84156 | 115 | 108 | $899.05 | |
| 00910 | 648 | 588 | $861.52 | |
| 86900 | 28 | 26 | $860.47 | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 23 | 20 | $826.80 |
| 87210 | 216 | 184 | $735.06 | |
| 86003 | 18 | 14 | $692.61 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 2,177 | 1,855 | $658.15 |
| 84520 | 112 | 111 | $654.16 | |
| 80339 | 32 | 30 | $645.06 | |
| 99201 | 14 | 13 | $617.93 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 180 | 149 | $612.75 |
| 85045 | 89 | 78 | $600.28 | |
| 86430 | 29 | 29 | $588.17 | |
| J2704 | Injection, propofol, 10 mg | 3,161 | 2,267 | $572.50 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 19 | 15 | $544.35 |
| 88187 | 12 | 12 | $516.24 | |
| 97802 | 13 | 12 | $515.43 | |
| 96376 | 33 | 28 | $503.95 | |
| 86850 | 28 | 26 | $494.11 | |
| 97803 | 14 | 14 | $491.48 | |
| 87205 | 94 | 84 | $476.29 | |
| 83615 | 30 | 25 | $461.24 | |
| 72220 | 14 | 13 | $432.74 | |
| 73090 | 13 | 13 | $423.70 | |
| 86039 | 14 | 14 | $384.61 | |
| 86901 | 28 | 26 | $379.89 | |
| 86200 | 13 | 13 | $283.12 | |
| 80334 | 17 | 17 | $279.14 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 1,204 | 838 | $259.97 |
| 80337 | 17 | 17 | $245.19 | |
| 86308 | 15 | 12 | $232.28 | |
| 73140 | 14 | 13 | $223.15 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1,407 | 1,231 | $199.59 |
| 84480 | 15 | 14 | $188.40 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 134 | 120 | $166.88 |
| 84165 | 28 | 25 | $159.23 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 811 | 649 | $152.84 |
| 99152 | 148 | 123 | $137.76 | |
| 80361 | 39 | 39 | $125.61 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 3,204 | 2,536 | $109.54 |
| 88300 | 15 | 15 | $102.00 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 66 | 55 | $93.00 |
| J3490 | Unclassified drugs | 68 | 50 | $88.61 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 2,567 | 1,889 | $84.02 |
| C9113 | Injection, pantoprazole sodium, per vial | 84 | 72 | $79.07 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 146 | 116 | $65.98 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 371 | 331 | $65.93 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 3,027 | 2,490 | $62.73 |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | 52 | 39 | $60.18 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 443 | 395 | $47.39 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 139 | 130 | $34.64 |
| J2785 | Injection, regadenoson, 0.1 mg | 66 | 64 | $23.91 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 31 | 31 | $14.24 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 22 | 14 | $8.81 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 104 | 99 | $8.71 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 22 | 20 | $7.06 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 79 | 63 | $2.81 |
| J1956 | Injection, levofloxacin, 250 mg | 217 | 190 | $2.50 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 187 | 162 | $1.62 |
| 00731 | 165 | 141 | $0.00 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 19 | 17 | $0.00 |